Title : Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells.

Pub. Date : 2014

PMID : 24067162






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells. Telmisartan peroxisome proliferator activated receptor alpha Homo sapiens
2 In this study, we assessed the effect of telmisartan on the expression of PPAR-alpha and lipoprotein lipase (LPL). Telmisartan peroxisome proliferator activated receptor alpha Homo sapiens
3 PPAR-alpha expression was detected by reverse-transcription polymerase chain reaction and Western blot in HepG2 hepatocytes as well as differentiated C2C12 myocytes treated with increasing concentrations of telmisartan (0.1-10 mumol/L) for 48 h. Results showed that 1 mumol/L and 10 mumol/L telmisartan significantly increased the expression of PPAR-alpha mRNA and protein in HepG2 cells (p < 0.01). Telmisartan peroxisome proliferator activated receptor alpha Homo sapiens
4 PPAR-alpha expression was detected by reverse-transcription polymerase chain reaction and Western blot in HepG2 hepatocytes as well as differentiated C2C12 myocytes treated with increasing concentrations of telmisartan (0.1-10 mumol/L) for 48 h. Results showed that 1 mumol/L and 10 mumol/L telmisartan significantly increased the expression of PPAR-alpha mRNA and protein in HepG2 cells (p < 0.01). Telmisartan peroxisome proliferator activated receptor alpha Homo sapiens
5 Similarly, 1 micromol/L and 10 mumol/L telmisartan significantly increased the expression of LPL mRNA and protein in HepG2 cells (p < 0.01), and this increase was significantly (p < 0.01) inhibited by the PPAR-alpha-specific antagonist MK886. Telmisartan peroxisome proliferator activated receptor alpha Homo sapiens